The relationship between red blood cell deformability metrics and perfusion of an artificial microvascular network by Sosa, Jose M. et al.
The relationship between red blood cell deformability metrics
and perfusion of an artificial microvascular network
Jose M. Sosa1, Nathan D. Nielsen2, Seth M. Vignes1, Tanya G. Chen1, and Sergey S.
Shevkoplyas1,*
1
 Department of Biomedical Engineering, Tulane University, New Orleans, LA 70118
2
 Department of Pulmonary Disease, Critical Care & Environmental Medicine, Tulane University
School of Medicine, New Orleans, LA 70112
Abstract
The ability of red blood cells (RBC) to undergo a wide range of deformations while traversing the
microvasculature is crucial for adequate perfusion. Interpretation of RBC deformability
measurements performed in vitro in the context of microvascular perfusion has been notoriously
difficult. This study compares the measurements of RBC deformability performed using
micropore filtration and ektacytometry with the RBC ability to perfuse an artificial microvascular
network (AMVN). Human RBCs were collected from healthy consenting volunteers,
leukoreduced, washed and exposed to graded concentrations (0% – 0.08%) of glutaraldehyde (a
non-specific protein cross-linker) and diamide (a spectrin-specific protein cross-linker) to impair
the deformability of RBCs. Samples comprising cells with two different levels of deformability
were created by adding non-deformable RBCs (hardened by exposure to 0.08% glutaraldehyde) to
the sample of normal healthy RBCs. Ektacytometry indicated a nearly linear decline in RBC
deformability with increasing glutaraldehyde concentration. Micropore filtration showed a
significant reduction only for concentrations of glutaraldehyde higher than 0.04%. Neither
micropore filtration nor ektacytometry measurements could accurately predict the AMVN
perfusion. Treatment with diamide reduced RBC deformability as indicated by ektacytometry, but
had no significant effect on either micropore filtration or the AMVN perfusion. Both micropore
filtration and ektacytometry showed a linear decline in effective RBC deformability with
increasing fraction of non-deformable RBCs in the sample. The corresponding decline in the
AMVN perfusion plateaued above 50%, reflecting the innate ability of blood flow in the
microvasculature to bypass occluded capillaries. Our results suggest that in vitro measurements of
RBC deformability performed using either micropore filtration or ektacytometry may not
represent the ability of same RBCs to perfuse microvascular networks. Further development of
biomimetic tools for measuring RBC deformability (e.g. the AMVN) could enable a more
functionally relevant testing of RBC mechanical properties.
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Introduction
The continual flow of blood through the human microvasculature ensures the transport of
dissolved gases, nutrients and regulatory molecules throughout the body as well as the
prompt removal of metabolic waste products. Adequate perfusion of the microvasculature
depends on several important hemorheological parameters including blood plasma viscosity,
hematocrit, red blood cell (RBC) aggregation, and particularly the ability of individual
RBCs to deform (e.g. contort, twist, change shape) when flowing through microvessels
ranging in size from 100 μm arterioles down to the smallest 3 μm capillaries.[1-7]
Alterations in RBC deformability have been associated with pathophysiological insults in
conditions as diverse as diabetes mellitus, sickle cell anemia, malaria, sepsis, and
postischaemic reperfusion.[8-14] A reduction in RBC deformability sometimes precedes
more severe and often irreversible pathological changes in other vital organs and organ
systems, and in some cases may even be the root cause of organ injury.[15-21]
A continuous research effort has been focused over the years on the development of
instruments for measuring the mechanical response of RBCs to various deforming forces at
either the single-cell or multi-cell level, and thus quantifying RBC “deformability”.[22] The
two techniques most frequently utilized in the vast majority of research performed to date in
this area (and perhaps most accessible in the clinical settings) are the micro-pore filtration
assay[23-30] and ektacytometry.[31-43] In this paper, we directly compare the
measurements of RBC deformability performed using these two methodologies with the
ability of RBCs to perfuse an artificial microvascular network (AMVN), a microfluidic
device developed in our laboratory for modeling the dynamics of blood flow and traffic of
circulating cells in the microvasculature.[44-47] We completed the comparison using RBC
samples with cell deformability artificially impaired via graded exposure to glutaraldehyde
(a non-specific protein cross-linker) and to diamide (a spectrin-specific cross-linker), both of
which are frequently used to determine the sensitivity of various deformability metrics.[42,
48-51] We found that the two methodologies were often in disagreement with each other,
and that neither micro-pore filtration nor ektacytometry could accurately predict the ability
of RBC samples to perfuse the AMVN. Our results support the notion that RBC
deformability is not a unique property but is rather operationally defined by the
measurement methodology, and emphasize the need for the development of biomimetic
tools for a more relevant assessment of RBC mechanical properties.
Materials and Methods
Blood Samples
Human whole blood was collected from healthy consenting volunteers by venipuncture into
6 mL Vacutainer tubes (K2EDTA, BD, Franklin Lakes, NJ, USA). Plasma was removed by
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centrifugation (800×g for 5 minutes, 22°C) and discarded. Pelleted RBCs were re-suspended
in 50 mL of phosphate buffered saline (PBS, Sigma, St. Louis, USA) and passed through a
leukoreduction filter (Purcell NEO, Pall Corporation, Port Washington, NY, USA). The
leukoreduced RBC suspension was washed in PBS once (800×g for 5 minutes, 22°C), and
adjusted to a 40% hematocrit.
Glutaraldehyde Treatment
The solution of glutaraldehyde (8% w/v, Sigma, St. Louis, USA) was diluted in PBS to form
stock solutions with concentrations of glutaraldehyde corresponding to twice the targeted
final concentrations. RBC samples (leukoreduced and washed as described above) were
combined with a stock solution of glutaraldehyde (1:1 v/v) to expose the cells to
glutaraldehyde concentrations in the range from 0.02 to 0.08% (w/v). The cells were
incubated in glutaraldehyde for 10 minutes at room temperature (22°C), and then the cross-
linking reaction was quenched by adding about 50 mL of an isotonic glucose- and albumin-
containing saline-phosphate (GASP) buffer (1% w/v bovine serum albumin, 9 mM
Na2HPO4, 1.3 mM NaH2PO4, 140 mM NaCl, 5.5 mM glucose, pH 7.4, 290 mmol kg-1).
Immediately after quenching, the treated RBCs were washed in the GASP buffer (800×g, 2
min) and the excess buffer was removed to adjust the hematocrit to 40%. In order to prepare
RBC suspensions containing 0%, 10%, 50% and 100% of hardened cells, the 40%
hematocrit suspension of RBCs that were exposed to 0.08% glutaraldehyde (as described
above) was mixed a different ratios with a 40% hematocrit suspension of fresh, untreated
RBCs.
Diamide Treatment
A suspension of RBCs (prepared as described above) was washed once in GASP, and its
hematocrit was adjusted to 45%. A 1 mL aliquot of the 45% hematocrit suspension was
treated with 125 μL of a stock diamide solution (Sigma, St. Louis, USA) resulting in a 40%
hematocrit suspension and a final concentration of diamide ranging from 0.02 to 0.08%
(w/v). Samples were incubated for 20 minutes at 22°C and immediately analyzed. (Note that
the final hematocrit of diamide-treated RBCs was 40%, same as for the glutaraldehyde-
treated RBCs.)
Ektacytometry Measurements
The treated RBC samples were prepared for analysis in the microfluidic ektacytometer
RheoScan-D (RheoMeditech, Seoul, Korea) by re-suspending 6 μL of the 40% RBC
suspension in 0.6 mL of PVP (polyvinylpyrrolidone) in accordance with the protocol
suggested by the manufacturer. Each sample was analyzed using a 210 μm height cartridge
of the RheoScan-D to determine the elongation index (EI) for each RBC sample exposed to
shear stresses ranging from 1 to 17 Pa (the limits of the instrument). EI values at 3 Pa and 17
Pa were recorded for diamide and glutaraldehyde concentrations ranging from 0.02% to
0.08% in 0.02% increments and then normalized with respect to the untreated sample. The
normalized values (n = 4) were averaged and plotted versus their respective concentrations.
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Micro-pore Filtration Measurements
The micro-pore filtration protocol used in this study has been previously described by us in
detail.[45] Briefly, 5 μm track-etched polycarbonate filters (Nuclepore™, Whatman, GE
Healthcare Biosciences, Piscataway, NJ, USA) were pre-wetted with 40% ethyl alcohol and
then incubated in GASP buffer for 1 hour before use. Filtration time (FT) was defined as the
time it took a 200 μL sample to pass through the filter. Each individual filter was calibrated
using GASP buffer before performing the measurements on RBCs. The FT for treated RBCs
was measured by timing the passage of 200 μL of 1% hematocrit RBC suspensions being
tested through the filter. The RBC filterability was calculated as the ratio of FT for GASP
buffer (free of cells) and the FT for the RBC suspension being tested. These values were
recorded for diamide and glutaraldehyde concentrations ranging from 0.02% to 0.08% in
0.02% increments and then normalized with respect to the untreated sample. The normalized
values (n = 4) were averaged and plotted versus their respective concentrations.
Measurement of the Artificial Microvascular Network Perfusion
The artificial microvascular network (AMVN) devices used in this study were fabricated
using conventional photolithography techniques as described in detail in our previous
studies.[45-47] Briefly, the pattern of AMVN was transferred onto a silicon wafer
(University Wafer, South Boston, MA, USA) in bas-relief by exposing the wafer covered
with a 5 μm layer of negative photoresist (SU-8 2005, MicroChem Corp, Newton, MA,
USA) to UV light through a chrome photomask (Photo Sciences Inc., Torrance, CA, USA).
The three dimensional structure of the inlet and the outlet ports were created by depositing
small droplets of SU-8 2007 photoresist onto the outlines of the inlet and the outlet,
exposing these features to UV light and curing them.[46, 52] This patterned silicon wafer
acted as the master for molding many exact replicas of the AMVN out of
polydimethylsiloxane (PDMS, Slygard 184, Dow Corning Corp., Midland, MI, USA). The
access through-holes for the inlet (4 mm) and outlet (2 mm) of the PDMS replica were
created using cylindrical biopsy punches (Acuderm Inc, Fort Lauderdale, FL, USA). The
AMVN devices were assembled by exposing the patterned side of the PDMS replica and the
surface of a glass slide (spin-coated with a thin film of PDMS) to air plasma (120 sec,
PDC-3xG, Harrick Plasma, Ithaca, NY, USA) and sealing them together. Assembled
AMVN devices were filled with 1% solution of mPEG-silane (Laysan Bio, Inc., Arab, AL,
USA) in GASP solution, and were incubated at 22°C in 100% humidity overnight to
suppress possible RBC adhesion to channel walls during the experiments.
The measurement of the AMVN perfusion was performed following the protocol developed
in our previous studies.[45, 46] Briefly, to perform an experiment, the assembled and treated
AMVN devices were placed onto the mechanical stage of an inverted microscope (IX71,
Olympus America Inc., Center Valley, PA, USA). The microscope was equipped with a
high-speed, high-sensitivity camera (MC1362, Mikrotron GmbH, Unterschleissheim,
Germany) connected to a Camera Link frame grabber (PIXCI E4, EPIX Inc., Buffalo Grove,
IL, USA) installed in a desktop computer. A narrow band-pass blue filter (394 ± 50nm,
B-390, Hoya Corp., Fremont, CA, USA) was used to improve the contrast of the images
(RBCs appear dark in blue light). A simple water column was used to provide the pressure
difference between the inlet and the outlet of the AMVN device. In the beginning of each
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AMVN measurement, the driving pressure difference was set to zero, the RBC sample was
loaded into the inlets of the device, and the acquisition of short sequences of images (10
frames, every 10 seconds, for 10 minutes) was initiated. The driving pressure difference was
then set to 20 cm H2O, and kept constant for the duration of the measurement. The acquired
images were analyzed using customary algorithm written in MATLAB (The Math Works
Inc., Natick, MA, USA) to determine the average RBC velocity in the arteriole of the
AMVN. The steady state value of the average RBC velocity was used to calculate the
overall flow rate through the arteriole (perfusion) of the AMVN.[46] The overall flow rate
for each sample treated with glutaraldehyde or diamide (concentrations varying from 0.02%
to 0.08%, with 0.02% increments) were normalized with respect to the untreated sample.
Normalized values were averaged over four individual trials and plotted versus their
respective concentrations.
Statistical analysis
Data were presented as mean ± standard deviation of individual measurements performed on
multiple independent samples. The measurements of RBC deformability performed with
different techniques were compared using the two-tailed, two-sample unequal variance t-
test. The differences were deemed statistically significant for p<0.05.
Results
Conventional techniques for measuring RBC deformability
Figure 1 illustrates the two conventional methodologies for measuring RBC deformability
used in this study – micro-pore filtration (Fig. 1A) and ektacytometry (Fig. 1B). In the
micro-pore filtration assay, the deformability of RBCs is evaluated by measuring the time it
takes a set volume of a dilute RBC suspension to pass through a thin polycarbonate
membrane containing capillary-size pores (usually a 5 μm Nuclepore filter).[45, 53] Unlike
in the microvasculature in vivo, each RBC deforms only once while passing through a pore
of the filter, which may limit its sensitivity. This measurement is known to be affected
primarily by the size and sphericity of individual RBCs, and is often confounded by the
plugging of pores by residual leukocytes and cellular clumps contaminating the tested
sample, and / or by even a small fraction of non-deformable RBCs.[54]
Ektacytometery evaluates RBC deformability by quantifying the degree of elongation of
RBCs suspended in a highly-viscous solution of polyvinylpyrrolidone (PVP) and subjected
to a well-defined shear stress field.[55-58] In this study, we used a microfluidic
ektacytometer (RheoScan-D, Fig. 1B) to measure RBC deformability at shear stresses
varying continually from 1 Pa up to 17 Pa (technical limit of the instrument).[42] In the
microfluidic ektacytometer, a laser beam is passed through a RBC sample flowing in a
microfluidic channel (0.2mm × 5mm × 40mm), and the change in the laser diffraction
pattern is measured to quantify the RBC elongation, and therefore RBC deformability.
Ektacytometry at low shear stresses (typically 3 Pa) is most sensitive to RBC membrane
properties, and at high shear stresses (e.g. 17 Pa) it primarily reflects so-called “maximal
deformability”, which is determined by the RBC geometrical parameters (i.e., the cell
surface area to volume ratio).[22, 36] The measurement of RBC deformability using
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ektacytometry is confounded by several important factors, including: (a) the viscosity of the
PVP solution is about 30-times larger than that of plasma, which is not physiological and
thus completely changes the mechanical response of RBCs to shear (i.e. RBCs subjected to
shear in plasma flip, not elongate), and (b) the hematocrit of RBC suspension tested is
extremely low (<0.5%) and thus ektacytometry cannot account for RBC deformations due to
cellular collisions (which are abundant in real blood flow).
Perfusion of the artificial microvascular network
Figure 2 illustrates the artificial microvascular network (AMVN) device used in this study.
[46, 47] This microfluidic device incorporated a network of capillary-size, 5 μm-deep
microchannels ranging in width from 5 to 70 μm, arranged in a pattern inspired by the
architecture of rat mesenteric microvasculature in vivo.[44, 45, 59] The fabrication of the
AMVN device and the methodology of the AMVN perfusion measurement has been
recently described in detail elsewhere.[46] To perform a measurement of the AMVN
perfusion, we passed a 40% hematocrit suspension of RBCs through the network under a
constant pressure difference between the inlet and the outlet (ΔP = 20 cmH2O), and
quantified the overall flow rate through the venule of the network (Fig. 2A). The value of
the AMVN perfusion rate reflects the effective ability of RBCs to undergo a wide range of
deformations as the cells pass through the network of artificial capillaries ranging in size
from 5 μm to 70 μm.[46] Figure 2 demonstrates the various deformations experienced by
RBCs flowing at a 40% hematocrit through the AMVN. These include the most basic
deformations of the cells into the characteristic bullet (Fig. 2D) and parachute (Fig. 2E)
shapes, as well as deformations in larger vessels (Fig. 2G) and in bifurcations (Fig. 2C and
2F) of the network due to cell-cell and cell-wall interactions. The primary advantage of the
AMVN device is that it directly measures the effective ability of RBCs to perfuse a
microvascular network, and performs this highly integrative measurement under
physiologically-relevant conditions, suspended in normal viscosity buffers or plasma at
physiological hematocrits, or even as whole blood. Much like in the AMVN, RBCs in vivo
must be able to deform in multiple ways to effectively perfuse the microvasculature and
perform their primary function of delivering oxygen to tissues. In this study, we used the
AMVN as a surrogate of the real microvasculature.
Comparison of the conventional deformability measurements with the ability of RBCs to
perfuse the AMVN
Figure 3 demonstrates the results of the comparison between the measurements of RBC
deformability performed using the two conventional techniques (micropore filtration and
ektacytometry) and the ability of the same RBCs to perfuse the AMVN. To perform this
comparison, we used three types of RBC samples with artificially altered overall
deformability: (1) healthy, fresh RBCs exposed to graded concentrations of glutaraldehyde,
(2) healthy, fresh RBCs exposed to graded concentrations of diamide, and (3) a mixture of
healthy, fresh RBCs with RBCs rendered non-deformable by exposure to 0.08%
glutaraldehyde. In all samples, RBCs were re-suspended in GASP buffer rather than in
autologous plasma to make sure that the AMVN perfusion measurements reflected RBCs
mechanical properties rather than viscosity of the suspending medium or RBC aggregation
behavior, and to maintain consistency with the previous work on ektacytometry and micro-
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pore filtration, most of which was done on RBCs re-suspended in various buffers rather than
in autologous plasma. For each RBC sample, all there measurements (micropore filtration,
ektacytometry and the AMVN perfusion) were performed simultaneously.
The measurement of RBC deformability using ektacytometry at both low (3 Pa) and high
(17 Pa) shear stresses declined nearly linearly with the increasing concentration of
glutaraldehyde (Fig. 3A). The value of RBC deformability measured using the micropore
filtration technique stayed relatively insensitive to the lower range of glutaraldehyde
concentrations (0-0.04%), and declined precipitously for the concentrations of
glutaraldehyde higher than 0.04% (Fig. 3A). The two techniques did not agree with each
other, but for the highest concentration of glutaraldehyde, 0.08%, at which point both
techniques showed nearly complete lack of deformability for the treated RBCs. The ability
of same RBCs to perfuse the AMVN declined linearly with the increasing concentration of
glutaraldehyde, to about 60% for the maximal concentration glutaraldehyde used in this
study (0.08%). Neither ektacytometry nor micropore filtration could accurately predict the
AMVN perfusion, with ektacytometry significantly overestimating and micropore filtration
underestimating (except for 0.08%) the effect of the glutaraldehyde-induced impairment of
RBC deformability on the network perfusion. For example, at the glutaraldehyde
concentration of 0.04%, ektacytometry showed a reduction in RBC deformability of 50% at
low shear stress (3 Pa) and 40% at high shear stress (17 Pa), whereas micropore filtration
showed only a 4% reduction in RBC deformability and the AMVN perfusion was reduced
by 14% for the same RBC sample (Fig. 3A).
Incubation of RBCs with increasing concentrations of diamide did not produce a measurable
change in RBC deformability as measured by the micropore filtration technique, and did not
affect the ability of same RBCs to perfuse the AMVN (Fig. 3B). In this sense, the micropore
filtration and the AMVN perfusion measurements were in excellent agreement with each
other. In sharp contrast, the measurement of deformability of the same RBCs performed
using ektacytometry declined precipitously starting at 0.02% diamide concentration,
reaching its minimal level plateau of 50% for low (3 Pa) and 80% for high (17 Pa) shear
stresses at concentrations higher than 0.06% (Fig. 3B). The ektacytometry measurements
could not predict the ability of the same RBCs to perfuse the AMVN for any concentration
of diamide above 0.02%.
In addition to the samples in which the deformability of all RBCs was affected by the graded
exposure to either glutaraldehyde or diamide, we also investigated how well ektacytometry
and micropore filtration could predict the AMVN perfusion for samples comprising a
mixture of deformable RBCs and non-deformable RBCs (Fig. 3C). To prepare these
samples we mixed healthy, normal RBCs with varying proportions of RBCs hardened by the
treatment with 0.08% glutaraldehyde, the maximal concentration of glutaraldehyde used in
this study that resulted in nearly complete loss of deformability by treated RBCs as
measured using ektacytometry and micropore filtration (Fig. 3A). The deformability of
RBCs in the mixed samples declined linearly with the increasing fraction of non-deformable
RBCs as measured using either micropore filtration or ektacytometry at high and low shear
rates (Fig. 3C). Both ektacytometry and micropore filtration were able to predict the ability
of the mixed samples to perfuse the AMVN very well, but only up to the 50:50 ratio of
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deformable and non-deformable RBCs. An increase in the fraction of non-deformable RBCs
to 100% resulted in only about 8% reduction of AMVN perfusion, while conventional
techniques showed a significant further decline of RBC deformability – 38% for
ektacytometry at low (3 Pa) shear rate, 47% for ektacytometry at high (17 Pa) shear rate, and
52% for micropore filtration (Fig. 3C).
Discussion
The deformability of RBCs is a multifactorial property that depends on membrane elasticity,
cytoplasmatic viscosity, volume-to-surface ratio and the tank treading motion, with each of
these variables affected differently by various pathophysiological processes and by the
treatments used in this study.[60, 61] Our results suggest that neither ektacytometry nor
micropore filtration can reliably predict the ability of RBCs with impaired deformability to
perfuse a network of capillary microchannels (Fig. 3). Micropore filtration and
ektacytometry evaluate two rather different aspects of RBC rheology – micropore filtration
measures only the ability of RBCs to undergo folding deformations (relevant primarily to
their entry into narrow capillaries), whereas ektacytometry measures only the ability of
RBCs to elongate when subjected to a very well defined shear stress field in a highly viscous
environment. The primary advantage of our approach over these two commonly used
techniques is that in the AMVN RBCs experience a much wider spectrum of deformations,
which includes the folding deformations in capillaries and the shear-induced deformations in
larger vessels, and their properties are tested while suspended in normal-viscosity buffers (or
even in blood plasma) at hematocrits that are physiologically-high and highly variable
across vessels of different size (much like in real microvasculature[62-65]).[45, 46] In this
sense, the measurement of AMVN perfusion rate provides a more realistic assessment of
RBC rheology and (because the AMVN evaluates RBC mechanical properties directly in
terms of microvascular perfusion) the results of this assessment should be easier to interpret
clinically and may have more significant diagnostic implications.[22]
One of the most important differences between the conventional techniques for measuring
RBC deformability, and the AMVN perfusion measurement is the biomimetic ability of the
AMVN to resist the detrimental effect of plugging of individual capillaries by non-
deformable cells on the overall network perfusion. In many physiologically relevant
conditions (e.g. sickle cell disease, malaria, blood transfusion), the distribution of
deformability throughout the RBC population is not homogeneous, with only a fraction of
all RBCs sustaining a significant impairment of their mechanical properties. In our
experiments with samples containing mixtures of healthy, normal RBCs and RBCs rendered
non-deformable by treatment with 0.08% glutaraldehyde (see Fig. 3A micropore filtration)
[45] the AMVN perfusion for these samples declined almost linearly with the increasing
fraction of non-deformable RBCs up to 50%, in good agreement with the two conventional
techniques (Fig. 3C). The subsequent increase of the fraction of non-deformable cells from
50% to 100% however, resulted in only an 8% reduction of the AMVN perfusion, whereas
there was a further decline in RBC deformability of 52% as measured by micropore
filtration, and a 38% decline for low shear (3 Pa) and a 47% decline for high shear (17 Pa)
ektacytometry (Fig. 3C). Overall, the AMVN perfusion declined by less than 50% before
reaching a plateau, suggesting that the flow of blood through the network was diverted to the
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larger microchannels, bypassing the plugged capillaries.[45] This behavior reflects a similar
microcirculatory dynamics observed in vivo, where in the AMVN as in mammalian
microcirculatory beds, RBCs have multiple pathways through which they can pass even if
smaller vessels are occluded by less deformable RBCs.[53, 66]
The main objective of this study was to investigate whether the measurements of RBC
deformability performed using the two conventional techniques (ektacytometry and micro-
pore filtration) could predict the ability of same RBCs to perfuse an artificial microvascular
network. In this context, we used the AMVN with a particular architecture (Fig. 2B) as a
representative example of such a network. A significant alteration of the network
architecture would affect the specifics of the blood flow dynamics within the network and
therefore the measurement of the network perfusion. This feature is in fact an important
advantage of our approach because the architecture of the AMVN could, in principle, be
designed to mimic the microvasculature of a target organ of interest (e.g. kidney, brain,
heart) and thus enable an organ-specific prediction of the impact of RBC mechanical
properties on microvascular perfusion. We believe, however, the results of our current study
and conclusions we drew from them in this paper are general in nature and therefore will
hold true with respect to a reasonable variation of the network architecture. A separate future
study designed to measure the effect of systematic variations in the network architecture on
the perfusion measurement would be able to test this hypothesis definitively.
Glutaraldehyde is a non-specific protein cross-linker that affects proteins present in all three
structural regions of a mature RBC, including those in the cytosol, as well as the cytoskeletal
and transmembrane proteins.[48, 50, 51, 67-70] Diamide is a sulfhydryl-oxidizing reagent
that exclusively cross-links spectrin via the formation of disulfide bonds within the RBC
cytoskeleton.[48, 71] Controlled exposure to glutaraldehyde and / or diamide is widely used
in the literature to mimic the pathophysiological impairment of RBC mechanical properties
occurring naturally, particularly in validation and sensitivity studies of new RBC
deformability measurement techniques.[36, 42, 43, 45, 48, 53, 71] A high sensitivity of a
technique for measuring RBC deformability to either of these chemical treatments, however,
may not necessarily mean a similarly high sensitivity to the other treatment (Fig. 3A-B).
In the ektacytometer, the deformability of RBCs is measured by quantifying the diffraction
pattern of a laser beam passing through a ~0.5% hematocrit suspension of RBCs in a high-
viscosity (30 mPa·s) solution of poly(vinylpyrrolidone). When subjected to shear stress in
such a highly viscous environment (>10x viscosity of plasma), RBCs do not flip, but rather
elongate in response, affecting the laser diffraction pattern and the readout of the technique.
Our measurements showed that RBC elongation under the conditions of ektacytometry is
highly sensitive to both the treatment of RBCs with glutaraldehyde (Fig. 3A) and with
diamide (Fig. 3B). This was not however the case for either micropore filtration or the
AMVN perfusion measurements.
In micropore filtration, the deformability of RBCs is measured by quantifying the time it
takes a fixed volume of a dilute suspension of RBCs (in saline or another normal viscosity
aqueous buffer solution) to pass through 5-μm pores of a thin membrane. To pass through
the smaller pores, each RBC in the suspension must undergo a single folding deformation.
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Under the conditions of the micropore filtration assay, the ability of RBCs to fold into the
capillary-size pores declined mildly after the treatment with the lowest concentrations of
glutaraldehyde. At the concentrations higher than 0.04%, the RBC mechanical properties
deteriorated precipitously, losing nearly all of their original deformability at the maximal
exposure (Fig. 3A) (in complete agreement with previous studies).[45, 53] In a striking
contrast with ektacytometry and despite the evident sensitivity to glutaraldehyde, the ability
of treated RBC to negotiate the capillary-size pores in the micropore filtration assay was
completely unaffected by the treatment with diamide (Fig. 3B). Similarly, the ability of
RBCs to perfuse the AMVN declined linearly with increasing concentration of
glutaraldehyde (Fig. 3A), but remained completely unaffected by exposure of RBCs to
diamide over the entire range of concentrations (Fig. 3B). A possible explanation of our
observations is that spectrin-specific cross-linking of the cytoskeleton affects the ability of
RBCs to elongate in response to applied shear stress when suspended in a high-viscosity
buffer (ektacytometry), but does not affect the ability of RBCs to deform when passing
through capillary-size pores (micropore filtration) and traversing a network of capillary
microchannels (AMVN). Our findings are consistent with previous studies, also reporting
differential sensitivity of various in vitro measurement techniques (including ektacytometry
and micropore filtration) to the treatments with glutaraldehyde and diamide.[48, 71, 72]
By the same token, it is highly unlikely that treating normal, healthy RBCs with either
glutaraldehyde or diamide represents any of the changes in RBC mechanical properties
occurring naturally as a functional manifestation of genetic abnormalities, due to metabolic
alterations, in response to a changing biochemical microenvironment or as a result of a
pathological process. In this context, high sensitivity of a particular measurement technique
to the chemically induced impairment of RBC deformability does not necessarily mean a
similar level of sensitivity to the real changes occurring in vivo. For example, Berezina et al.
used the micropore filtration technique to quantify the progressive deterioration of RBC
mechanical properties during a 6-week hypothermic storage, and found that by day 42 of
storage RBC deformability was 46% lower than for fresh cells.[25] In a more recent study,
Henkelman et al. used ektacytometry to investigate the evolution of RBC mechanical
properties during 7 weeks of hypothermic storage. They found that deformability of stored
RBCs did not change at the shear stress of 3.9 Pa throughout storage. At a higher shear
stress of 50 Pa, the deformability of stored RBCs in the beginning of storage (3 days after
donation) was about 9% higher than for fresh RBCs, but then gradually decreased to about
2% higher than for fresh RBCs by the end of storage.[40] For comparison, in our own recent
study we measured a 26% ± 4% decline in the ability of RBCs to perfuse the AMVN after a
41-day hypothermic storage.[46]
In our measurements performed on the same RBC samples simultaneously, micropore
filtration was significantly less sensitive to the impairment of RBC deformability caused by
the treatment with glutaraldehyde than ektacytometry (Fig. 3A); unlike ektacytometry,
micropore filtration was also completely insensitive to the treatment with diamide (Fig. 3B).
Using these data it is logical to make a conclusion that ektacytometry is a more sensitive
technique for measuring RBC deformability than micropore filtration. Yet, when used to
quantify the deterioration of RBC mechanical properties caused by the same biological
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process (storage lesion), micropore filtration reported a significant loss of nearly half of
RBC deformability by the end of storage,[25] while the ektacytometry measurements
suggested a slight improvement with respect to fresh RBCs.[40] The marked disagreement
between the sensitivity of the two techniques to the chemically-induced and the natural
impairment of RBC mechanical properties highlights the danger of using the treatment with
glutaraldehyde and/or diamide as the benchmark when developing, optimizing and
validating novel techniques for measuring RBC deformability. More studies focused on the
side-by-side comparison of various RBC deformability measurement techniques, and more
representative models of the natural RBC deformability impairment for calibrating these
techniques in vitro are urgently needed.
Conclusion
This study compared the measurements of RBC deformability performed using two very
commonly employed techniques, micropore filtration and ektacytometry, and investigated
how well these measurements could predict the ability of same RBCs to perfuse an artificial
microvascular network (AMVN). The two conventional techniques did not agree with each
other, and could not accurately predict the ability of the RBCs with artificially impaired
deformability to perfuse the AMVN. Our study reinforces the notion that RBC deformability
is not a unique property, but rather a property that is operationally defined by the
measurement methodology. This seemingly obvious realization highlights the need for any
study of RBC deformability to employ multiple measurement methods in order to benefit
from the descriptive strengths of the different technologies and perform a multi-parameter,
comprehensive evaluation of RBC mechanical response to deforming forces. A vast
majority of RBC deformability studies published to date base their conclusions on a single
measurement method. While the insights gleaned from these studies are certainly valuable,
they may give a one-dimensional, biased assessment because of the attempt to reduce the
multifaceted nature of such a complex phenomenon as RBC deformability to a single
numerical value. One way towards a much more balanced and potentially more clinically
meaningful assessment of RBC mechanical properties is to invest a significant research
effort into the development and careful validation of novel biomimetic techniques and
devices that can test RBC behavior in the mechanical microenvironment closely mimicking
the dynamics of blood flow in the microvasculature. We speculate that the measurement of
perfusion of an artificial microvascular network (AMVN) to evaluate the mechanical
properties of RBCs is a significant step towards this important goal.
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Figure 1.
Illustration of the two conventional technologies commonly used to evaluate RBC
deformability. (A) In the micro-pore filtration technique, RBCs are passed through 5 μm
pores of a polycarbonate filter. The time it takes a pre-set volume of the RBC suspension to
pass through the filter (filtration time) is measured to evaluate the ability of RBCs to
undergo folding deformations when passing through narrow openings. (B) In an
ektacytometer (RheoScan-D), a dilute suspension of RBCs in a highly viscous PVP solution
is passed through a stright channel at various shear stresses. A laser beam is passed
perpendicularly through the RBC suspension and the change in the diffraction pattern is
quantified via the calculation of the elongation index to evaluate RBC deformability.
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Figure 2.
Illustration of the artificial microvascular network (AMVN) device. (A) In the AMVN
device, a 40% hematocrit suspension of RBCs is passed through a network of artificial
capillaries under a constant pressure difference between the inlet and the outlet, and the
overall flow rate in the venule of the AMVN is quantified. (B) The AMVN perfusion rate
evaluates the effective ability of RBCs to undergo a variety of deformations as they pass
through the network of artificial capillaries ranging in size from 5 μm to 70 μm. (C) RBCs
deform as a result of collisions with other cells and vessel walls at capillary bifurcations. (D)
RBCs passing through the narrowest capillaries assume the characteristic bullet-like shape.
(E) RBCs deform into the parachute shape in larger capillaries. (F) RBCs experience
significant deformations due to the convergence of two streams moving with different
velocities. (G) In largest vessels of the AMVN, RBCs undergo shear-induced deformations
as well as deformations caused by multiple collisions with other cells in bulk flow. The flow
direction is from left to right in all images. Scale bars are 10μm.
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Figure 3.
A comparison of the normalized deformability indices measured using different
methodologies for RBCs incubated with graded concentrations of (A) glutaraldehyde and
(B) diamide, and (C) for reconstituted samples containing a mixture of healthy normal cells
and varying percentage of non-deformable RBCs hardened by incubation with 0.08%
glutaraldehyde. Each data point represents mean ± standard deviation of n = 4 samples (*
p<0.05 with respect to every other measurement technique).
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